US Stock MarketDetailed Quotes

KZIA Kazia Therapeutics

Watchlist

1.745
-0.025-1.41%

Close Jan 2 16:00 ET

1.780
+0.035+2.01%

Post 20:01 ET

7.60MMarket Cap-0.28P/E (TTM)

Kazia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kazia Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2023/H2	22.970K / 11.500K	--
--	2023/H1	140.000 / 1.100K	--
--	2022/H2	110.000 / 338.670K	--
--	2022/H1	26.950K / 0.000	--
--	2021/H2	15.180M / 18.700M	--

DatePeriodRevenue/EstimateEarnings Call

--2023/H222.970K / 11.500K--

--2023/H1140.000 / 1.100K--

--2022/H2110.000 / 338.670K--

--2022/H126.950K / 0.000--

--2021/H215.180M / 18.700M--

Unlock Free Earnings Estimates

Open Account

Kazia Therapeutics Earnings Reports

Kazia Therapeutics | 20-F: FY2024 Annual Report

Nov 15, 2024 16:10 ET

Kazia Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 19, 2024 16:31 ET

Kazia Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 27, 2024 08:29 ET

Kazia Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Dec 6, 2023 08:31 ET

Trending US Stocks

Symbol Mini Chart % Chg

Unlock the Full List